Clinical studies 13 have demonstrated HPG dysfunction among some men suffering from depressive disorders. A study 14 showed that elderly men between ages 60 and 82 years with dysthymic disorder had significantly lower total testosterone concentrations (mean total testosterone 11 nmol/l) than their counterparts with major depressive disorder (mean total testosterone 14.9 nmol/l) and those without depression (mean total testosterone 15.1 nmol/l). The majority of elderly men with dysthymic disorder had total testosterone concentrations in the hypogonadal range (i.e.:
Objective
The study compared serum testosterone concentrations and the bio-available fraction in men older than 45 years suffering from major depressive disorder, and in healthy age-matched controls.
Our hypothesis was that the depressed men would have lower serum testosterone concentrations than the age-matched control group. The age-matched control group were recruited from the same geographical area and met the same inclusion and exclusion criteria, except that they had not suffered from a past or present mood or other psychiatric disorder and scored zero on all the items of the measures of depression (see below). No differences between the depressed and control groups were apparent in their socio-economic circumstances and racial profiles. The body mass index of all subjects was less than 25.
Material and methods

Subjects
Measures
The HAM-D and the Montgomery-Asberg Depression Rating
Scale (MADRS) 6 were used to measure the severity of depressive features. Although these observer-rated instruments measure the same thing in general, we used both in order to increase the validity of our measurements as some of their respective items used to gauge severity are not shared.
Total serum testosterone, bio-available testosterone and the calculated free testosterone concentrations were measured quantitatively according to standardised laboratory tests, using inter-radio-immuno-assay variation coefficients.
Venous blood was collected from all subjects and controls. All blood was collected before 10h00 in the morning in order to avoid the effects of diurnal variation in serum testosterone concentrations. 7 It was centrifuged and frozen within 4 hours of being collected, and analysed within 3 months of being frozen.
Statistical analysis
After the normality of all the data had been tested, the depressed group was compared with the control group using unpaired Student's t-tests, and a linear multiple regression analysis was performed on the data.
Results
The mean age of all the subjects was 54.9 years (standard deviation (SD) 8.14 years). A cumulative frequency graph showed that the ages in the depressed and control group were well matched (Fig. 1) . The mean scores of the depressed group 
Discussion
The main finding of this study was that testosterone concentrations in men above the age of 45 years suffering from a major depressive disorder were statistically significantly lower than levels in an age-matched control group without depression.
This finding was observed for total testosterone and for free testosterone concentrations, but more strikingly for bio-available testosterone concentrations.
Strengths and limitations
The main strength of this study is that it was case controlled for age. As far as we can establish, it is the first study on the subject to do so. Our findings, like those of other studies, 8, 9 support the importance of accounting for age. First, there was a significant negative correlation between bio-available testosterone and the ages of men in the depressed group and the control The strength of our findings, furthermore, resides in the selection of subjects, even though the sample size was relatively small. The study group all suffered from depression to at least a moderate degree of severity, whereas the control group did not have any current depressive features, nor did they have a present or past psychiatric disorder. Night-shift workers who may have altered diurnal variation in their testosterone circadian rhythm and patients suffering from endocrinological conditions, which may have confounded the results, were excluded from both groups.
The control group, moreover, consisted of healthy volunteers rather than being from an ill population.
In addition to the progressive age-related decline in testosterone concentrations, the diurnal rhythm of testosterone secretion also wanes with age. Testosterone secretion is usually at its highest in the early morning and lowest (about 20% less than the peak value)
in the late afternoon. 3 Our study attempted to reduce the influence of the usual diurnal variation of testosterone concentrations as a potential confounding variable, by obtaining blood samples from both groups before 10h00 in the morning. A difference in diurnal variation in testosterone concentrations between the depressed and control groups could nonetheless be the reason for the observed differences in testosterone concentrations between the groups. All the same, this would suggest that the difference in diurnal variation is related to the depressive illness.
This cross-sectional study does not provide insight as to whether lower testosterone concentration is a cause or consequence of depressive illness among men above 45 years of age.
Longitudinal cohort and/or experimental studies would better serve such purposes.
Ageing and serum testosterone concentrations
The decrease in testosterone concentrations in healthy ageing men is the result of combined testicular changes, altered neuroendocrine regulation of Leydig cell function and the independent increase of serum sex hormone binding globulin (SHBG) concentrations. 10 Mean serum total testosterone concentrations in the male population decrease by about 30% and bio-available testosterone decreases by about 50% from the age of 25 to 75 years. 11 Yet only about 7% of men in the 40 -60-year age group have serum testosterone concentrations below the limit for young adults but the figure rises to 20% in the 60 -80-year age group. 
Implications and future research
Particularly useful would be follow-up studies that develop a risk index; the risk of developing a depressive disorder may then be calculated based on age and testosterone concentrations. 
Limitations
Limitations of the study include the following: (i) the study does not provide insight as to whether lower testosterone concentrations are a cause or consequence of depressive illness among men above 45 years of age; (ii) a difference in diurnal variation in testosterone concentrations between the depressed and control groups could have been the reason for the observed differences in testosterone concentrations between the groups; and (iii) the sample size was relatively small.
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